← Directory

RetinAI Discovery

RetinAI

FDA clearedAMDgeographic atrophydiabetic retinopathyDMEglaucoma

Vendor-neutral platform that collects OCT and fundus data from multiple devices and layers on AI analysis; its OCT Atlas algorithm covers AMD, GA, DR, DME and glaucoma.

FDA clearance covers image management; AI outputs not confirmed within cleared indications.

Company
RetinAI
Category
Imaging analysis
Reads
OCT volumes, fundus images, DICOM and proprietary device formats
Built for
Clinics, hospitals, researchers, pharma
Billing
Check vendor
Regulatory
FDA 510(k) K211715 (Apr 28, 2022), product code NFJ (ophthalmic image management system). The K number covers image management; vendor says OCT Atlas is CE-marked for clinical use. Whether the AI biomarker outputs are within FDA-cleared indications was not confirmed. · source
Last verified
2026-10-07

DotAEye is independent of RetinAI. Confirm indications, intended use, and clearance status with the manufacturer before clinical use.